
Trade aggression: India's steel shield mustn't turn into a slippery slope
Fears of surplus production overseas being dumped in India, especially by Chinese manufacturers, have spiked amid the ongoing tariff war. On Monday, India's ministry of finance notified a safeguard duty of 12% for 200 days on five categories of steel imports if sold below specified dollar prices.
These include hot rolled coils, sheets and plates; hot rolled plate mill plates; cold rolled coils and sheets; metallic coated steel coils and sheets; and colour coated coils and sheets. This follows the preliminary findings of a probe by the Directorate General of Trade Remedies (DGTR), which had noted a 'recent, sudden, sharp and significant increase in imports" of these goods, putting
domestic producers
at the threat of 'serious injury."
Government data shows that our steel imports rose to 9.5 million tonnes in 2024-25 from 8.3 million tonnes the previous year. Shipments from South Korea, Japan and other countries have been under the DGTR scanner, but particularly imports from China, whose economic slowdown has led to a steel glut.
As dumping is an unfair trade practice that hurts local businesses, anti-dumping levies are allowed under World Trade Organization (WTO) rules, so long as they're proportionate, temporary and based on evidence. Even without WTO caveats, this device must always be used judiciously. After all, if duties are raised on industrial inputs, user industries could suffer higher costs; if levied on finished goods, consumers may end up paying more.
As there is often a thin line between safeguard duties and outright protectionism, all stakeholders within the country and abroad should have clarity on the rationale employed. In the case of steel products, the Centre's notice refers to a DGTR report of 18 March that lays out trends on excess capacity overseas and a surge in our import volumes, along with indexed data on how prices were undercut.
To establish injury, it shows how indexed local profits and employment took big hits. It has other supportive numbers too. In fact, the 93-page document seems overloaded with tabulations. Ideally, in such cases, the government should also offer an executive summary to explain why the action was taken. This would keep the scope for doubt minimal.
Price information is key. A sudden drop in import prices is a telltale sign of wares being dumped. Deep-discount sales can also be inferred from a comparison of prices charged by producers in their home markets and here. Clinching evidence that satisfies the textbook definition of below-cost dumping would require the actual production costs of foreign exporters, but these are difficult to obtain and Chinese data would be clouded by subsidies doled out by the state—a reason it's blamed for warping fair trade.
The shield erected in defence of Indian steelmakers not only appears WTO-compliant, it is in line with actions taken by many other nations. A clearer enunciation of its logic, however, would deter dubious demands from sundry other industries that may want to be shielded from global competition. While business lobbies can hardly be blamed for trying, safeguard duties levied on flimsy grounds would push up costs all around. Several quality control orders issued by the Centre are already suspected of acting as non-tariff barriers.
New hurdles raised across the economy for imports would leave us with a higher cost base, which would deal a blow to our global competitiveness. All said, we must take care that a shield for steel doesn't turn into a slippery slope.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Mint
17 minutes ago
- Mint
Ajit Ranade: The success of ‘Made in China 2025' alarmed the West
An after-effect of the global financial crisis of 2008 was that by the following year, China's exports dropped by 16%. This led to widespread factory closures and mass layoffs in provinces like Guangdong. China's prosperity had been built on the large-scale export of low-cost, labour-intensive manufactured goods for three decades. The crisis exposed the vulnerability of that strategy and overdependence on Western markets. Also, China was stuck in low-end assembly roles in global supply chains, with low value addition. Undoubtedly, its economic reforms from 1978 onwards made it possible for 300 million workers to move from rural and agricultural livelihoods to higher paying industrial and urban jobs. But 2008 was a rude reminder of several weaknesses. Real wages had not grown much. As a result, consumption spending was stuck at just 35% of GDP even as late as 2009. Domestic demand could not pick up the slack caused by falling external demand. Also Read: Kaushik Basu: Redefine prosperity; GDP tunnel-vision could prove costly In 2009, Chinese policymakers responded with a 4 trillion renminbi stimulus, with big spending on infrastructure. This restored growth to 10% next year, but also led to industrial overcapacity in sectors like steel and cement, and reinforced the dominance of state-led investment. Consumption was not picking up even as deflationary pressures were building, while state-owned enterprises were struggling, plagued by overcapacity. This in turn caused a debt explosion. China's debt has grown from 150% of GDP in 2008 to about 280% now. A real estate over-build-up made a crisis in this sector imminent, as was later demonstrated by the fall of Evergrande. This was the backdrop to Beijing's launch of 'Made in China 2025' (MIC25) ten years ago. By 2013, the new regime under President Xi Jinping had recognized the need for supply-side reforms by cutting overcapacity, addressing the consumption-export imbalance and reviving industrial growth with innovation and value addition. Also Read: China began de-risking its economy well before Trump's trade fury Partly inspired by Germany's Industrie 4.0, MIC25 aimed to upgrade Chinese manufacturing to high value addition and less dependence on foreign technology. It also aimed for technological self-sufficiency and domination of emerging high-tech sectors, and sought to promote indigenous innovation and green as well as smart manufacturing. It targeted 10 sectors, including aerospace, advanced rail-transport equipment and new energy vehicles, and aimed to raise the domestic content in high-tech industries to 70%. This industrial policy was focused on picking champions, channelling vast state subsidies, and guiding credit and support to chosen sectors from preferential government procurement. The West was unhappy, viewing MIC25 as mercantilist and violative of WTO norms as well as non-market driven. There were concerns about forced technology transfer and cyber theft. Unsurprisingly, when US President Donald Trump assumed office for his first term, he slapped punitive duties, put in export controls and investment screening. The EU followed suit in trying to decouple from China. Also Read: The time is right for a reset of India's trade ties with China Fast forward to 2025. There are now several independent assessments of MIC25. Of these, two major studies were commissioned by the American Chamber and European Chamber of Commerce. What emerges is that MIC25 has been a success and has led to a spree of backlash actions, such as this year's Trump tariffs. China now accounts for 30% of value added in global manufacturing, ahead of the US, which accounts for 16%. China's BYD dominates electric vehicles (EVs), while Huawei leapt ahead in 5G telecom and AI hardware. China is a leader in shipbuilding, batteries, solar power, turbines, drones, consumer electronics and pharmaceutical ingredients. DeepSeek's AI leap was a wake-up call to those enamoured by OpenAI's ChatGPT. The recent price slash by BYD shook the global EV industry. It sells more vehicles than Tesla in the EU despite higher tariffs. China now has more robots per 10,000 workers than Germany, according to a Financial Times report. Import dependency has reduced and foreign companies are incentivized to localize production. EVs, high speed rail, industrial robots, 5G and renewable energy are China's success stories, while it faces challenges in semiconductors, aerospace and biomedicine. The FT report notes that even now, Chinese aircraft are simply 'western aircraft with Chinese metal on them." Other risks are its huge EV and solar overcapacity, apart from the global backlash of tariffs and sanctions led by US actions. Hence, MIC25 has been repositioned and folded into a broader framework called 'new quality productive forces." Also Read: How Trumpian volatility is forcing policy changes in China At the rate it is going, China's share of valued addition in manufacturing could go up to 50% in the next 5-10 years. How this Cold War 2.0, which may see the US decouple from China, plays out is anybody's guess. China is also investing in trying to win the war of narratives and perception by describing its alternate development path. But initiatives like its Belt and Road plan have only met with limited success. China also cannot ignore some core and persistent vulnerabilities, including low domestic consumption demand, an ageing demography as well as a peaking labour force, rising unemployment, slowing growth and ballooning debt. Added to this is its increased friction with the Western world and barriers denying its exports access to markets in the West. The success of MIC25 cannot hide these related risks and challenges. The author is senior fellow with Pune International Centre.


News18
20 minutes ago
- News18
French Firm Servier Drops Exclusive Deal For Selling High BP Drugs After Chemists' Pushback
Last Updated: After successful mediation by offline chemists, Servier promptly withdrew the agreement – which is seen as a positive step towards preserving the fairness of open trade practices. In a major development impacting the pharmaceutical distribution landscape in India, an Indian arm of French drugmaker Servier has officially withdrawn its exclusive distribution agreement for its anti-hypertensive product line, reverting to conventional distribution practices. The move comes after the apex lobby of offline chemists, All India Organisation of Chemists and Druggists (AIOCD), raised concerns, alleging the potential monopolistic implications of Servier's deal with Entero Healthcare, a supply chain specialist company. AIOCD represents more than 12 lakh chemists and distributors in India, pushing Servier to discontinue the arrangement of supplying certain products via Entero. The majority of the AIOCD's partners refused to sell the drugs sold by the French drugmaker. After facing industry pushback, in a letter dated May 26, 2025, Servier India informed its trade partners that it has 'discontinued exclusive distribution arrangement for anti-hypertensive range of products" with immediate effect. The letter has been seen by News18. This update follows a formal communication by AIOCD on May 28, addressing the issue. The letter detailed how many members of the organisation had expressed concerns over the exclusivity agreement, warning that it could lead to discriminatory trade practices, shortages in essential medications, and the formation of monopolistic structures within the pharmaceutical supply chain. AIOCD, in a letter, said that the organisation mediated with Servier to ensure a fair resolution. 'After successful mediation by AIOCD, the company has promptly withdrawn the said exclusive distribution agreement. This is a positive and encouraging step toward preserving the balance and fairness in our open trade practices," the letter read. The development is being seen as a victory for chemists and druggists across India, many of whom feared market distortions and reduced access to essential medicines due to exclusive arrangements. 'We have had fruitful discussions with AIOCD. Servier India is focused on improving patient access to our quality medicines. We will continue to engage constructively with all stakeholders," Aurelien Breton, managing director, Servier India told News18. Brenton told News18 that he is thankful to AIOCD 'for the constructive dialogue, which allowed us to resolve the matter amicably in the interest of the healthcare community and patients at large." 'Servier is a global pharmaceutical group governed by a nonprofit foundation, committed to making a meaningful social impact for patients and contributing to a sustainable world." Headquartered in France, Servier operates in around 140 countries. Sources close to the development told News18 that, 'Servier's management rushed the distributor appointment, with inadequate market assessment and due diligence. However, now, it has made right decision following the general rules of the Indian pharma trade market." First Published: June 02, 2025, 12:40 IST


Mint
20 minutes ago
- Mint
Bank of Maharashtra to Crompton Greaves - Vinay Rajani of HDFC Sec suggests these 3 stocks to buy in the near-term
Stock market today: The Indian stock markets began the new week on a downbeat trend, influenced by global worries in spite of solid domestic GDP data. The benchmark indices fell as investor sentiment was affected by the renewed tariff threats from US President Donald Trump. At 12:34 IST, the Nifty 50 index was trading at 24,715 . 95, showing a drop of 35.70 points or 0.15%. Sensex was trading lower at 81,325.42, decreasing by 125.59 points or 0.15%. This pressure emerged following Trump's announcement to modify tariffs on steel and aluminum, which has rekindled fears of a trade conflict and economic pressures. Market analysts pointed out that although India's macroeconomic fundamentals are robust, as demonstrated by the strong GDP figures, the external challenges posed by the US tariff adjustments have overshadowed domestic gains. The potential for a broader impact on global trade and capital movements has led investors to exercise caution. Vinay Rajani of HDFC Securities recommends Bank of Maharashtra, Crompton Greaves Consumer Electricals Ltd, and City Union Bank Ltd. Check out his overall market views. Nifty 50 continued its consolidation for the second consecutive week with a weekly fall of 0.41%. Bank Nifty managed to outperform Nifty 50 with a gain of 0.33% and closed at an all-time high. Sectoral indices like PSU Bank, Capital market and Defense outperformed the benchmark with the weekly gain of 4.08%, 3.35% and 2.73% respectively. Indices like FMCG, tourism, and commodities underperformed by falling 2.16%, 1.90% and 1.61% respectively. The Nifty Microcap250 index rose 1.47% and managed to outperform Nifty 50 with a good margin. Nifty 50 has been protecting its level above 20 days EMA and SMA, placed 20,630 and 20,692 respectively. A level above all key moving averages indicates a bullish trend on all time frames for Nifty 50. Any level above 25,116 would confirm the bullish breakout from the consolidation. The lower band of the consolidation is placed near 24,400 levels, below which short term would turn bearish. Above 25,116, Nifty 50 could move towards immediate resistance of 25,300 odd levels, which happens to be 78.6% retracement of the entire fall seen from all time high of 26277 to recent swing low of 21743. Above 25300, We expect Nifty 50 to hit a new all-time high above 26277 and go beyond. Midcap and Microcap indices have been showing strength, which shows the strong breadth in the market. The Bank Nifty index has closed at fresh all-time highs with recent outperformance. Both PSU and Private bank stocks are looking strong on the chart and likely to take a lead in the coming sessions. Nifty Capital Market index has given a fresh breakout above its previous all-time highs. Considering the momentum and the chart setup, this index is likely to extend its gain in the coming days. Ratio Chart of Copper v/s Gold indicates that Copper should start outperforming gold from here for the medium to long term. Historically, Copper used to have a positive correlation with equity markets. Primary trend is bullish but short-term consolidation is going on in the Nifty 50. Traders should continue to hold on to the long positions with 24,462 stoploss in the Nifty 50. Any level above 25,116 will confirm the fresh bullish breakout. Above 25,116, we can expect Nifty 50 to extend the rise towards 25,300. Above 25,300 Nifty 50 could register fresh all-time highs. Vinay Rajani of HDFC Securities recommends these three stocks in the near term - Bank of Maharashtra, Crompton Greaves Consumer Electricals Ltd, and City Union Bank Ltd. Bank of Maharashtra share price surged 6% on 30 th May with big jump in volumes. Stock has been in to a primary uptrend as it has been sustaining above its key moving averages. PSU Bank index has broken out from the consolidation on the medium-term chart. Weekly MACD is now placed above signal and equilibrium line. Breakout from Symmetrical triangle pattern on the weekly chart. City Union Bank share price has been sustaining above 200 DEMA resistance. Stock price is now placed above 20, 50 and 200 days EMA. Monthly RSI has reached above 50, indicating sustainable up trend. Weekly MACD is now placed above signal and equilibrium line On week ended 16 th May 2025, Crompton Consumer share price broke out from downward sloping trend line on the weekly chart. Price rise was accompanied by a jump in volumes. Stock price has been sustaining above 50 DEMA resistance. Weekly RSI has reached above 50, indicating a sustainable up trend. Weekly MACD is now placed above signal line. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.